Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remote Monitoring of Interstitial Lung Disease to Provide Continuity of Care and Shielding From Risks Associated With In-clinic Assessment

NCT04850521 is registered in ClinicalTrials.gov with patientMpower Ltd. as lead sponsor.

NCT NCT04850521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04850521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remote Monitoring of Interstitial Lung Disease to Provide Continuity of Care and Shielding From Risks Associated With In-clinic Assessment
Lead sponsor
patientMpower Ltd.
Phase
Observational
Overall status
Completed
Start date
August 3, 2021
Completion date
July 7, 2022
Enrollment
60 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease